Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Close-field electroporation gene delivery for damaged cochlear hair cells regeneration

May 29, 2014

Novartis plans phase I/II study of CGF-166

May 15, 2014

Oricula Therapeutics receives NIH grant to further develop medicine to preserve hearing

May 2, 2014

Oricula Therapeutics secures intellectual property and funding to prevent hearing loss

April 10, 2014

Amarantus acquires option to license intellectual property for MANF and CDNF

March 10, 2014

Auris Medical enrolls first patient in European study of AM-101 in peripheral tinnitus

Feb. 25, 2014

Third milestone achieved in GenVec and Novartis collaboration

Feb. 17, 2014

Audion Therapeutics and Lilly to develop hearing loss treatments

Feb. 11, 2014

New potassium channel modulators patented by Autifony Therapeutics

Dec. 16, 2013

Otonomy's OTO-201 reduces treatment failure in subjects undergoing ear tube placement surgery

Aug. 21, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...